Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001516551-24-000070
Filing Date
2024-08-09
Accepted
2024-08-09 17:18:47
Documents
67
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q skye-20240630.htm   iXBRL 10-Q 800150
2 EX-10.1 a101_skyebio-inducementequ.htm EX-10.1 149914
3 EX-10.2 a102_skyebioscience-induce.htm EX-10.2 48640
4 EX-10.3 a103_skyebio-formofrestric.htm EX-10.3 61845
5 EX-31.1 skye-20240630xex311.htm EX-31.1 10490
6 EX-31.2 skye-20240630xex312.htm EX-31.2 11019
7 EX-32.1 skye-20240630xex321.htm EX-32.1 5071
8 EX-32.2 skye-20240630xex322.htm EX-32.2 5211
  Complete submission text file 0001516551-24-000070.txt   5243336

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20240630.xsd EX-101.SCH 39333
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skye-20240630_cal.xml EX-101.CAL 58404
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skye-20240630_def.xml EX-101.DEF 185212
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20240630_lab.xml EX-101.LAB 532517
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20240630_pre.xml EX-101.PRE 357765
70 EXTRACTED XBRL INSTANCE DOCUMENT skye-20240630_htm.xml XML 560217
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42009 | Film No.: 241194020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)